Global Hereditary Angioedema Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hereditary Angioedema Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Hereditary Angioedema Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Hereditary Angioedema Drug by Country/Region, 2017, 2022 & 2028

2.2 Hereditary Angioedema Drug Segment by Type

2.2.1 C1 Esterase Inhibitor

2.2.2 Kallikrein Inhibitor

2.2.3 Selective Bradykinin B2 Receptor Antagonist

2.3 Hereditary Angioedema Drug Sales by Type

2.3.1 Global Hereditary Angioedema Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Hereditary Angioedema Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Hereditary Angioedema Drug Sale Price by Type (2017-2022)

2.4 Hereditary Angioedema Drug Segment by Application

2.4.1 Retail Pharmacies

2.4.2 Hospital Pharmacies

2.4.3 Online Pharmacies

2.5 Hereditary Angioedema Drug Sales by Application

2.5.1 Global Hereditary Angioedema Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Hereditary Angioedema Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Hereditary Angioedema Drug Sale Price by Application (2017-2022)

3 Global Hereditary Angioedema Drug by Company

3.1 Global Hereditary Angioedema Drug Breakdown Data by Company

3.1.1 Global Hereditary Angioedema Drug Annual Sales by Company (2020-2022)

3.1.2 Global Hereditary Angioedema Drug Sales Market Share by Company (2020-2022)

3.2 Global Hereditary Angioedema Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Hereditary Angioedema Drug Revenue by Company (2020-2022)

3.2.2 Global Hereditary Angioedema Drug Revenue Market Share by Company (2020-2022)

3.3 Global Hereditary Angioedema Drug Sale Price by Company

3.4 Key Manufacturers Hereditary Angioedema Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hereditary Angioedema Drug Product Location Distribution

3.4.2 Players Hereditary Angioedema Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Hereditary Angioedema Drug by Geographic Region

4.1 World Historic Hereditary Angioedema Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Hereditary Angioedema Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Hereditary Angioedema Drug Annual Revenue by Geographic Region

4.2 World Historic Hereditary Angioedema Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Hereditary Angioedema Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Hereditary Angioedema Drug Annual Revenue by Country/Region

4.3 Americas Hereditary Angioedema Drug Sales Growth

4.4 APAC Hereditary Angioedema Drug Sales Growth

4.5 Europe Hereditary Angioedema Drug Sales Growth

4.6 Middle East & Africa Hereditary Angioedema Drug Sales Growth

5 Americas

5.1 Americas Hereditary Angioedema Drug Sales by Country

5.1.1 Americas Hereditary Angioedema Drug Sales by Country (2017-2022)

5.1.2 Americas Hereditary Angioedema Drug Revenue by Country (2017-2022)

5.2 Americas Hereditary Angioedema Drug Sales by Type

5.3 Americas Hereditary Angioedema Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hereditary Angioedema Drug Sales by Region

6.1.1 APAC Hereditary Angioedema Drug Sales by Region (2017-2022)

6.1.2 APAC Hereditary Angioedema Drug Revenue by Region (2017-2022)

6.2 APAC Hereditary Angioedema Drug Sales by Type

6.3 APAC Hereditary Angioedema Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Hereditary Angioedema Drug by Country

7.1.1 Europe Hereditary Angioedema Drug Sales by Country (2017-2022)

7.1.2 Europe Hereditary Angioedema Drug Revenue by Country (2017-2022)

7.2 Europe Hereditary Angioedema Drug Sales by Type

7.3 Europe Hereditary Angioedema Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hereditary Angioedema Drug by Country

8.1.1 Middle East & Africa Hereditary Angioedema Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Hereditary Angioedema Drug Sales by Type

8.3 Middle East & Africa Hereditary Angioedema Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Hereditary Angioedema Drug

10.3 Manufacturing Process Analysis of Hereditary Angioedema Drug

10.4 Industry Chain Structure of Hereditary Angioedema Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Hereditary Angioedema Drug Distributors

11.3 Hereditary Angioedema Drug Customer

12 World Forecast Review for Hereditary Angioedema Drug by Geographic Region

12.1 Global Hereditary Angioedema Drug Market Size Forecast by Region

12.1.1 Global Hereditary Angioedema Drug Forecast by Region (2023-2028)

12.1.2 Global Hereditary Angioedema Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Hereditary Angioedema Drug Forecast by Type

12.7 Global Hereditary Angioedema Drug Forecast by Application

13 Key Players Analysis

13.1 Pharming Group NV

13.1.1 Pharming Group NV Company Information

13.1.2 Pharming Group NV Hereditary Angioedema Drug Product Offered

13.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pharming Group NV Main Business Overview

13.1.5 Pharming Group NV Latest Developments

13.2 Takeda

13.2.1 Takeda Company Information

13.2.2 Takeda Hereditary Angioedema Drug Product Offered

13.2.3 Takeda Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Takeda Main Business Overview

13.2.5 Takeda Latest Developments

13.3 CSL Limited

13.3.1 CSL Limited Company Information

13.3.2 CSL Limited Hereditary Angioedema Drug Product Offered

13.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CSL Limited Main Business Overview

13.3.5 CSL Limited Latest Developments

13.4 IBio Inc.

13.4.1 IBio Inc. Company Information

13.4.2 IBio Inc. Hereditary Angioedema Drug Product Offered

13.4.3 IBio Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 IBio Inc. Main Business Overview

13.4.5 IBio Inc. Latest Developments

13.5 BioCryst Pharmaceuticals, Inc.

13.5.1 BioCryst Pharmaceuticals, Inc. Company Information

13.5.2 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Offered

13.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 BioCryst Pharmaceuticals, Inc. Main Business Overview

13.5.5 BioCryst Pharmaceuticals, Inc. Latest Developments

13.6 Ionis Pharmaceuticals, Inc.

13.6.1 Ionis Pharmaceuticals, Inc. Company Information

13.6.2 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Offered

13.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Ionis Pharmaceuticals, Inc. Main Business Overview

13.6.5 Ionis Pharmaceuticals, Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Hereditary Angioedema Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Hereditary Angioedema Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of C1 Esterase Inhibitor

Table 4. Major Players of Kallikrein Inhibitor

Table 5. Major Players of Selective Bradykinin B2 Receptor Antagonist

Table 6. Global Hereditary Angioedema Drug Sales by Type (2017-2022) & (K Units)

Table 7. Global Hereditary Angioedema Drug Sales Market Share by Type (2017-2022)

Table 8. Global Hereditary Angioedema Drug Revenue by Type (2017-2022) & ($ million)

Table 9. Global Hereditary Angioedema Drug Revenue Market Share by Type (2017-2022)

Table 10. Global Hereditary Angioedema Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Hereditary Angioedema Drug Sales by Application (2017-2022) & (K Units)

Table 12. Global Hereditary Angioedema Drug Sales Market Share by Application (2017-2022)

Table 13. Global Hereditary Angioedema Drug Revenue by Application (2017-2022)

Table 14. Global Hereditary Angioedema Drug Revenue Market Share by Application (2017-2022)

Table 15. Global Hereditary Angioedema Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Hereditary Angioedema Drug Sales by Company (2020-2022) & (K Units)

Table 17. Global Hereditary Angioedema Drug Sales Market Share by Company (2020-2022)

Table 18. Global Hereditary Angioedema Drug Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Hereditary Angioedema Drug Revenue Market Share by Company (2020-2022)

Table 20. Global Hereditary Angioedema Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Hereditary Angioedema Drug Producing Area Distribution and Sales Area

Table 22. Players Hereditary Angioedema Drug Products Offered

Table 23. Hereditary Angioedema Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Hereditary Angioedema Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Hereditary Angioedema Drug Sales Market Share Geographic Region (2017-2022)

Table 28. Global Hereditary Angioedema Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Hereditary Angioedema Drug Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Hereditary Angioedema Drug Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Hereditary Angioedema Drug Sales Market Share by Country/Region (2017-2022)

Table 32. Global Hereditary Angioedema Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Hereditary Angioedema Drug Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Hereditary Angioedema Drug Sales by Country (2017-2022) & (K Units)

Table 35. Americas Hereditary Angioedema Drug Sales Market Share by Country (2017-2022)

Table 36. Americas Hereditary Angioedema Drug Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Hereditary Angioedema Drug Revenue Market Share by Country (2017-2022)

Table 38. Americas Hereditary Angioedema Drug Sales by Type (2017-2022) & (K Units)

Table 39. Americas Hereditary Angioedema Drug Sales Market Share by Type (2017-2022)

Table 40. Americas Hereditary Angioedema Drug Sales by Application (2017-2022) & (K Units)

Table 41. Americas Hereditary Angioedema Drug Sales Market Share by Application (2017-2022)

Table 42. APAC Hereditary Angioedema Drug Sales by Region (2017-2022) & (K Units)

Table 43. APAC Hereditary Angioedema Drug Sales Market Share by Region (2017-2022)

Table 44. APAC Hereditary Angioedema Drug Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Hereditary Angioedema Drug Revenue Market Share by Region (2017-2022)

Table 46. APAC Hereditary Angioedema Drug Sales by Type (2017-2022) & (K Units)

Table 47. APAC Hereditary Angioedema Drug Sales Market Share by Type (2017-2022)

Table 48. APAC Hereditary Angioedema Drug Sales by Application (2017-2022) & (K Units)

Table 49. APAC Hereditary Angioedema Drug Sales Market Share by Application (2017-2022)

Table 50. Europe Hereditary Angioedema Drug Sales by Country (2017-2022) & (K Units)

Table 51. Europe Hereditary Angioedema Drug Sales Market Share by Country (2017-2022)

Table 52. Europe Hereditary Angioedema Drug Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Hereditary Angioedema Drug Revenue Market Share by Country (2017-2022)

Table 54. Europe Hereditary Angioedema Drug Sales by Type (2017-2022) & (K Units)

Table 55. Europe Hereditary Angioedema Drug Sales Market Share by Type (2017-2022)

Table 56. Europe Hereditary Angioedema Drug Sales by Application (2017-2022) & (K Units)

Table 57. Europe Hereditary Angioedema Drug Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Hereditary Angioedema Drug Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Hereditary Angioedema Drug Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Hereditary Angioedema Drug Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Hereditary Angioedema Drug Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Hereditary Angioedema Drug

Table 67. Key Market Challenges & Risks of Hereditary Angioedema Drug

Table 68. Key Industry Trends of Hereditary Angioedema Drug

Table 69. Hereditary Angioedema Drug Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Hereditary Angioedema Drug Distributors List

Table 72. Hereditary Angioedema Drug Customer List

Table 73. Global Hereditary Angioedema Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Hereditary Angioedema Drug Sales Market Forecast by Region

Table 75. Global Hereditary Angioedema Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Hereditary Angioedema Drug Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Hereditary Angioedema Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Hereditary Angioedema Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Hereditary Angioedema Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Hereditary Angioedema Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Hereditary Angioedema Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Hereditary Angioedema Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Hereditary Angioedema Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Hereditary Angioedema Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Hereditary Angioedema Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Hereditary Angioedema Drug Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Hereditary Angioedema Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Hereditary Angioedema Drug Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Hereditary Angioedema Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Hereditary Angioedema Drug Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Hereditary Angioedema Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Hereditary Angioedema Drug Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pharming Group NV Basic Information, Hereditary Angioedema Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. Pharming Group NV Hereditary Angioedema Drug Product Offered

Table 95. Pharming Group NV Hereditary Angioedema Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Pharming Group NV Main Business

Table 97. Pharming Group NV Latest Developments

Table 98. Takeda Basic Information, Hereditary Angioedema Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Takeda Hereditary Angioedema Drug Product Offered

Table 100. Takeda Hereditary Angioedema Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Takeda Main Business

Table 102. Takeda Latest Developments

Table 103. CSL Limited Basic Information, Hereditary Angioedema Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. CSL Limited Hereditary Angioedema Drug Product Offered

Table 105. CSL Limited Hereditary Angioedema Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. CSL Limited Main Business

Table 107. CSL Limited Latest Developments

Table 108. IBio Inc. Basic Information, Hereditary Angioedema Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. IBio Inc. Hereditary Angioedema Drug Product Offered

Table 110. IBio Inc. Hereditary Angioedema Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. IBio Inc. Main Business

Table 112. IBio Inc. Latest Developments

Table 113. BioCryst Pharmaceuticals, Inc. Basic Information, Hereditary Angioedema Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Offered

Table 115. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. BioCryst Pharmaceuticals, Inc. Main Business

Table 117. BioCryst Pharmaceuticals, Inc. Latest Developments

Table 118. Ionis Pharmaceuticals, Inc. Basic Information, Hereditary Angioedema Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Offered

Table 120. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Ionis Pharmaceuticals, Inc. Main Business

Table 122. Ionis Pharmaceuticals, Inc. Latest Developments

List of Figures

Figure 1. Picture of Hereditary Angioedema Drug

Figure 2. Hereditary Angioedema Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hereditary Angioedema Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Hereditary Angioedema Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Hereditary Angioedema Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of C1 Esterase Inhibitor

Figure 10. Product Picture of Kallikrein Inhibitor

Figure 11. Product Picture of Selective Bradykinin B2 Receptor Antagonist

Figure 12. Global Hereditary Angioedema Drug Sales Market Share by Type in 2021

Figure 13. Global Hereditary Angioedema Drug Revenue Market Share by Type (2017-2022)

Figure 14. Hereditary Angioedema Drug Consumed in Retail Pharmacies

Figure 15. Global Hereditary Angioedema Drug Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 16. Hereditary Angioedema Drug Consumed in Hospital Pharmacies

Figure 17. Global Hereditary Angioedema Drug Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 18. Hereditary Angioedema Drug Consumed in Online Pharmacies

Figure 19. Global Hereditary Angioedema Drug Market: Online Pharmacies (2017-2022) & (K Units)

Figure 20. Global Hereditary Angioedema Drug Sales Market Share by Application (2017-2022)

Figure 21. Global Hereditary Angioedema Drug Revenue Market Share by Application in 2021

Figure 22. Hereditary Angioedema Drug Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Hereditary Angioedema Drug Revenue Market Share by Company in 2021

Figure 24. Global Hereditary Angioedema Drug Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Hereditary Angioedema Drug Revenue Market Share by Geographic Region in 2021

Figure 26. Global Hereditary Angioedema Drug Sales Market Share by Region (2017-2022)

Figure 27. Global Hereditary Angioedema Drug Revenue Market Share by Country/Region in 2021

Figure 28. Americas Hereditary Angioedema Drug Sales 2017-2022 (K Units)

Figure 29. Americas Hereditary Angioedema Drug Revenue 2017-2022 ($ Millions)

Figure 30. APAC Hereditary Angioedema Drug Sales 2017-2022 (K Units)

Figure 31. APAC Hereditary Angioedema Drug Revenue 2017-2022 ($ Millions)

Figure 32. Europe Hereditary Angioedema Drug Sales 2017-2022 (K Units)

Figure 33. Europe Hereditary Angioedema Drug Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Hereditary Angioedema Drug Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Hereditary Angioedema Drug Revenue 2017-2022 ($ Millions)

Figure 36. Americas Hereditary Angioedema Drug Sales Market Share by Country in 2021

Figure 37. Americas Hereditary Angioedema Drug Revenue Market Share by Country in 2021

Figure 38. United States Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Hereditary Angioedema Drug Sales Market Share by Region in 2021

Figure 43. APAC Hereditary Angioedema Drug Revenue Market Share by Regions in 2021

Figure 44. China Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Hereditary Angioedema Drug Sales Market Share by Country in 2021

Figure 51. Europe Hereditary Angioedema Drug Revenue Market Share by Country in 2021

Figure 52. Germany Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Hereditary Angioedema Drug Revenue Market Share by Country in 2021

Figure 59. Egypt Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Hereditary Angioedema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Hereditary Angioedema Drug in 2021

Figure 65. Manufacturing Process Analysis of Hereditary Angioedema Drug

Figure 66. Industry Chain Structure of Hereditary Angioedema Drug

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles